It's that time of year again when the temperatures drop, and the number of illnesses rise across Oklahoma City. Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory ...
Opens in a new tab or window The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years and older, as well as for 60- to 74-year ...
Getting vaccinated against respiratory syncytial virus (RSV) around 32 weeks of pregnancy offers the best protection for newborn infants, according to a new study published in the American Journal of ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the years before the introduction of respiratory syncytial virus (RSV) vaccines, the virus was linked with ...
Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...
Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...
Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...
Timely diagnosis of RSV is imperative for optimal patient management; by rapidly identifying RSV infection, health professionals can implement appropriate infection control measures while limiting ...